OKYO Pharma Ltd SEC filings OKYO
OKYO Pharma Ltd has 311 filings in SEC EDGAR's recent list, going back to Mar 22, 2021. Its latest annual report, Form 20-F, was filed on Jul 20, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Nov 5, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Feb 17, 2026 | — |
| 424B5 | Prospectus supplement | Feb 12, 2026 | — |
| 424B5 | Prospectus supplement | Feb 11, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 2, 2026 | — |
| 424B5 | Prospectus supplement | Jun 11, 2025 | — |
| 424B5 | Prospectus supplement | Dec 20, 2023 | — |
| 424B5 | Prospectus supplement | Dec 18, 2023 | — |
| 424B5 | Prospectus supplement | Oct 31, 2023 | — |
| 424B5 | Prospectus supplement | Sep 15, 2023 | — |
| 424B5 | Prospectus supplement | Sep 13, 2023 | — |
| FWP | Free writing prospectus | Jul 28, 2023 | — |
| 424B5 | Prospectus supplement | Jul 28, 2023 | — |
| 424B3 | Prospectus | Jun 15, 2023 | — |
| F-1/A | Filing | Jun 9, 2023 | — |
| F-1/A | Filing | Jun 8, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 8, 2023 | — |
| F-1/A | Filing | Jun 2, 2023 | — |
| F-1 | Registration statement (foreign issuer) | May 17, 2023 | — |
| 424B4 | Prospectus | Mar 14, 2023 | — |
| POS AM | Filing | Mar 3, 2023 | — |
| F-1/A | Filing | Feb 22, 2023 | — |
| F-1/A | Filing | Feb 17, 2023 | — |
| FWP | Free writing prospectus | Jan 19, 2023 | — |
| F-1/A | Filing | Jan 19, 2023 | — |
| FWP | Free writing prospectus | Jan 3, 2023 | — |
| F-1/A | Filing | Jan 3, 2023 | — |
| FWP | Free writing prospectus | Dec 9, 2022 | — |
| F-1/A | Filing | Dec 9, 2022 | — |
| FWP | Free writing prospectus | Dec 6, 2022 | — |
| F-1 | Registration statement (foreign issuer) | Dec 5, 2022 | — |
| 424B4 | Prospectus | May 18, 2022 | — |
| FWP | Free writing prospectus | May 13, 2022 | — |
| F-1/A | Filing | May 13, 2022 | — |
| F-1/A | Filing | May 9, 2022 | — |
| F-6 | Filing | May 5, 2022 | — |
| F-1/A | Filing | May 4, 2022 | — |
| FWP | Free writing prospectus | Apr 29, 2022 | — |
| F-1/A | Filing | Apr 26, 2022 | — |
| F-1/A | Filing | Apr 14, 2022 | — |
| F-1/A | Filing | Mar 25, 2022 | — |
| F-1 | Registration statement (foreign issuer) | Mar 4, 2022 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- OKYO (Nasdaq)
- Headquarters
- London, United Kingdom
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1849296
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.